Want to track KALV and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
KalVista Pharmaceuticals Inc. (KALV) Statistics
Valuation metrics
Market Cap 1.44B
Enterprise value 1.49B
Trailing P/E (ttm) -8.36
Forward P/E 22.4
PEG ratio -0.56
Price/Sales (ttm) 12.4
Price/Book (mrq) -503.31
Enterprise Value/Revenue 12.88
Enterprise Value/EBITDA -12.74
Overview
Shares outstanding 51.24M
Float 33.25M
Shares short 15.16M
% Held by insiders 0.02%
% Held by institutions 1.37%
Average volume (10 days) 1.36M
Average volume (90 days) 2.82M
Price summary
52-Week low 9.83
52-Week high 27
Beta -0.12
50-Day moving average 27
200-Day moving average 19.57
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:14
Last split Date 22 Nov 2016
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -1.19%
Operating margin -1.21%
Operational effectiveness
Return on assets -0.41%
Return on equity -10.57%
Income Statement
Revenue (ttm) 114.48M
Revenue per share (ttm) 2.29
Quarterly revenue growth (yoy) 1.98%
Gross profit (ttm) 58.47M
EBITDA -138.45M
Net income to common (ttm) -135.94M
Diluted EPS (ttm) -2.74
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 285.03M
Total cash per share (mrq) 5.94
Total debt (mrq) 284.31M
Total Debt/Equity (mrq) -104.83
Current ratio (mrq) 5.58%
Book value per share (mrq) -0.05
Cash Flow
Cash flow statement -89.32M
Levered free cash flow (LFCF) -183.44M
